Morning Brew October 27 2026
Résumé: AI rebounds on Anthropic IPO
Good morning.
A rebound in AI shares has lifted equities, but high energy prices, the UK budget and this week’s central-bank decisions and economic data are keeping markets nervous.
Britain’s new finance minister, John Healey, delivers his first budget on Wednesday against a backdrop of rising global borrowing costs and high energy prices linked to the Iran war.
Budgets are a key event for UK markets, particularly since the 2022 mini-budget, when plans for unfunded tax cuts sparked a bond-market rout. Sterling weakened against a strengthening euro on Monday after reaching a roughly 17-month high on Friday.
HSBC’s third-quarter profit rose 32%, helped by favourable interest rates and limited credit losses. However, a marked slowdown in its wealth business highlighted the challenge of sustaining its recent strong performance. The bank’s Hong Kong-listed shares fell 5% after the results but remain up 11% year-to-date.
First-half revenue grew roughly fourteenfold, alongside around USD 637 billion in named multiyear computing arrangements.
The operating picture is improving: second-quarter operating profit reached USD 974 million, while Claude Code and Cowork offer opportunities to expand customer usage and spending.
U.S. equities snapped a two-day losing streak on Monday. The S&P 500 rose 0.7% to 7,677, the Nasdaq Composite gained 0.8% to 26,169 and the Nasdaq 100 advanced 1.1%. The Philadelphia Semiconductor Index surged 2.8%, its best session since 21 September, as Anthropic’s IPO filing and planned listing in the week of 16 November boosted sentiment. Tesla led the Magnificent Seven, jumping 5.2% after Barclays upgraded the stock, citing the potential for a deal with SpaceX. Nvidia gained 2.4%, while Meta fell 1.9% after disclosing plans to raise up to USD 95 billion through a stock offering. Lumentum rose 8.2%. U.S. equity-index futures are steady to slightly higher in early Asian trading on Tuesday.
European equities also ended a two-day losing streak on Monday. The Stoxx 600 rose 0.8% to 641, the DAX gained 0.9% to 25,411, the CAC 40 added 0.8% to 7,847 and the Euro Stoxx 50 advanced 0.8% to 6,116. Genmab surged 12% to a 52-week high after a positive late-stage trial update for an experimental cancer treatment. Rolls-Royce gained 6.1%, helping the FTSE 100 rise 0.7% to 10,767, while Computacenter jumped 13.1%. On the downside, Telefónica fell 7–8% and Santander lost 3–6% on their exposure to the Brazilian election.
Asia is rebounding this morning as well.
UBS and Deutsche Bank report tomorrow before the market opens. The impact of the bond selloff will be closely watched, alongside any comments from UBS on how it plans to address a possible increase in capital requirements.
Deloitte estimates that securities-based lending has reached around USD 5,400 billion, mostly secured against stock and bond portfolios, but also funds and crypto. The market has expanded sharply as more global wealth flows into markets and asset prices rise, with annual growth averaging 12% over the past decade.
Major currencies are trading nervously ahead of the UK budget, economic data and central-bank decisions. EUR/USD has fallen below 1.12 to 1.1166, GBP/USD is at 1.3330 and USD/JPY at 157.70. Gold is holding near 4,000, silver is lower at 53.35 and Bitcoin is trading below 80,000. It is somewhat strange that precious metals and crypto suffered as yields rose but are finding no relief now that yields are receding.
The Brazilian real tumbled more than 8%, its largest single-day decline since the 1990s, following Lula’s surprise re-election.
Expectations for the five central banks are largely unchanged. The Federal Reserve, ECB and Bank of Japan are almost certain to leave rates unchanged, while the Bank of Canada and Reserve Bank of New Zealand are likely to raise rates. In December, both the Fed and the ECB are likely to hike.
Bond yields are slightly lower, with the U.S. 10-year at 4.96%, France at 4.90%, the UK at 5.34%, Germany at 3.35% and Japan at 3.35%. Switzerland’s yield has fallen below 0.5%.
Brent crude settled near USD 116 in a volatile session, easing from last week’s six-month high near USD 117. Diplomatic efforts to ease U.S.–Iran tensions offered some relief, although Saudi–Houthi tensions and Middle East supply risks continue to underpin prices. European benchmark gas rose 2.8% to EUR 96.44 per MWh, a four-year high, on concerns about winter supplies.
The outlook remains volatile. Traders will be torn between risk management and optimism, with shifts in sentiment potentially triggering large moves for the rest of the week. Consider how much exposure to carry and the role options could play, both for protection and for speculative exposure.
Tuesday, 27 October 2026
Macro: U.S. durable goods orders, Conference Board consumer confidence and new home sales.
Central banks: Federal Reserve meeting begins.
Corporate earnings: Novartis and HSBC; Visa and Coca-Cola.
Wednesday, 28 October 2026
Central banks: Federal Reserve rate decision and press conference; Bank of Canada rate decision.
Corporate earnings: UBS, Deutsche Bank, Airbus and GSK; Unilever trading statement; Microsoft and Alphabet.
Thursday, 29 October 2026
Macro: U.S. advance Q3 GDP, personal income and spending, PCE inflation and initial jobless claims.
Central banks: ECB rate decision and press conference; Bank of Japan meeting begins.
Corporate earnings: Amazon Shell, TotalEnergies and ING; Eli Lilly, Mastercard and Merck.
Friday, 30 October 2026
Macro: Euro-area flash Q3 GDP and preliminary October inflation; U.S. Q3 Employment Cost Index; month-end flows.
Central banks: Bank of Japan rate decision and Outlook Report.
Corporate earnings: Sanofi, AstraZeneca and BP; ExxonMobil, Chevron and AbbVie.